Abstract
Objective
The primary objective was to test the hypothesis that clinical re-expansion pulmonary edema is predominantly due to increased permeability of the alveolar-capillary barrier. A secondary objective was to determine if the alveolar epithelium was functionally intact in patients with re-expansion pulmonary edema by measuring net alveolar epithelial fluid transport in a subset of patients.
Design
Retrospective study of mechanically ventilated patients with re-expansion pulmonary edema.
Setting
Two academic tertiary care hospitals.
Patients
Seven patients with acute onset of re-expansion pulmonary edema after tube thoracostomy or thoracentesis.
Interventions
Pulmonary edema fluid and plasma were collected at the time of onset of re-expansion edema.
Measurements and results
Contrary to our hypothesis, the mean initial edema fluid to plasma protein ratio was 0.58±0.21, supporting a hydrostatic mechanism of edema formation. Four of the patients had an initial edema fluid to plasma protein ratio of less than 0.65, consistent with pure hydrostatic pulmonary edema, while the others had a slight increase in permeability (edema fluid to plasma ratios of 0.67, 0.71 and 0.77), perhaps due to capillary stress failure from hydrostatic stress. Alveolar fluid clearance (mean 9.8±8.0%/h) was intact in the subset of three patients in whom it was measured.
Conclusions
This study provides the first direct evidence that hydrostatic forces may contribute to the development of re-expansion pulmonary edema.
Similar content being viewed by others
Introduction
Re-expansion pulmonary edema is a rare condition associated with the re-expansion of a collapsed lung after the drainage of fluid or air from the pleural space [1, 2, 3, 4, 5]. Re-expansion edema usually develops within 24 h of the drainage procedure and is characterized by acute arterial hypoxemia, decreased pulmonary compliance and patchy or diffuse alveolar infiltrates in the re-expanded lung with histologic evidence of pulmonary edema [6, 7]. Although most patients recover, re-expansion pulmonary edema can be fatal [8].
The mechanisms underlying re-expansion pulmonary edema have been investigated experimentally [9, 10, 11, 12] and indicate a possible role for neutrophils and increased capillary permeability. However, the pathogenesis of clinical re-expansion pulmonary edema has been studied in very few patients [6, 12, 13, 14] and the mechanisms in the clinical setting remain unclear. Furthermore, the capacity of the alveolar and distal airway epithelium to remove edema fluid in the setting of re-expansion pulmonary edema has never been studied.
We therefore collected undiluted pulmonary edema fluid and plasma from seven patients with acute re-expansion pulmonary edema. The primary objective was to test the hypothesis that re-expansion edema is predominantly due to increased permeability of the alveolar-capillary barrier. By sampling undiluted pulmonary edema fluid and plasma near the onset of re-expansion edema, it was possible to measure the edema fluid to plasma protein ratio, a direct measure of permeability of the alveolar capillary barrier [15, 16, 17]. In addition, in three patients we were able to determine if the alveolar epithelium was functionally intact by measuring changes in the protein concentration in serial pulmonary edema fluid samples; a rise in edema fluid protein concentration indicates net alveolar epithelial fluid transport [16, 18].
Methods
Patient selection and clinical data collection
Between 1984 and 2001, seven patients were identified with acute clinical re-expansion pulmonary edema within 24 h of thoracentesis or tube thoracostomy. Clinical criteria for the diagnosis of re-expansion pulmonary edema included the development of hypoxemia and new infiltrates in the re-expanded lung within 24 h of thoracentesis or tube thoracostomy. Medical records were comprehensively reviewed. All chest radiographs for each patient were reviewed by two of the investigators in conjunction with a radiologist. This study was approved by the Committee for Human Research at the University of California, San Francisco and the Institutional Review Board at the University of California, Los Angeles with a waiver of informed consent.
Collection of pulmonary edema fluid
The first pulmonary edema fluid sample was collected in all seven patients at the onset of clinically evident re-expansion pulmonary edema. Serial edema fluid samples at sequential time points up to 12 h after the initial sample were collected in three of the seven patients. Pulmonary edema fluid was collected by the authors or trained respiratory therapists as previously reported [16]. Briefly, a soft 14-Fr-gauge suction catheter was advanced into a wedged position in a distal bronchus via the endotracheal tube. Pulmonary edema fluid was collected in a suction trap by gentle suction. Simultaneous plasma samples were obtained. Pulmonary edema fluid was centrifuged at 14,000 g for 20 min and plasma samples were centrifuged at 3,000 g for 10 min. The supernatants were aspirated and stored at -70°C.
Protein determination and cell counts
Protein concentrations were measured in duplicate in thawed edema fluid supernatants and plasma by the Biuret method, as previously described [16]. Edema fluid cell and differential counting were carried out using standard methods in the hospital laboratory.
Calculation of edema fluid to plasma protein ratios and alveolar fluid clearance
The ratio of the protein concentration in pulmonary edema fluid to simultaneous plasma protein was calculated as previously described [16]. A ratio equal to or less than 0.65 is diagnostic of a hydrostatic mechanism of pulmonary edema, as we and other investigators have reported [16, 17, 19]. The net rate of alveolar fluid clearance was calculated by comparing the final and initial pulmonary edema fluid protein concentrations in patients with sequential samples. This rate was expressed as a percent clearance per hour to estimate the net clearance of fluid across the distal airway and alveolar epithelium [20]. These methods have been previously validated in dog and sheep lungs [21, 22, 23], as well as in clinical studies of human pulmonary edema [16, 17, 24, 25, 26].
Results
A summary of patient clinical characteristics is presented in Table 1. All patients had the acute onset of radiographically confirmed pulmonary edema after thoracentesis or tube thoracostomy that was clinically severe and required intubation and mechanical ventilation. Prior to the drainage procedure there was no evidence of pulmonary edema in any patient. No patient had evidence of any other underlying cause of pulmonary edema, such as acute lung injury or heart failure, that would alter the protein concentrations present in the airspace fluid or the fluid-absorbing capability of the alveolar epithelium. Three patients ultimately died. Patient 1 died from the consequences of a cardiac arrest. Patient 3 died from widespread lymphoma; at autopsy there was evidence of pulmonary edema, but no histologic evidence of diffuse alveolar damage. Patient 4 died from pericardial tamponade due to lymphomatous involvement of the pericardium.
Pulmonary edema fluid analysis
The mean initial edema fluid to plasma protein ratio, a measure of alveolar-capillary barrier permeability was 0.58±0.21, suggesting that hydrostatic forces contributed to the formation of pulmonary edema in these patients. Four of the seven patients had an initial edema fluid to plasma protein ratio less than 0.65 (Table 1), consistent with pure hydrostatic pulmonary edema. Three patients had edema fluid to plasma protein ratios greater than 0.65 (mean value of 0.72), a finding that is consistent with a modest increase in protein permeability [16, 17, 19]. There was no correlation between the time interval from drainage to edema fluid sampling and the initial edema fluid to plasma protein ratios (Table 2).
In five patients, sufficient pulmonary edema fluid was obtained to analyze cell counts. The edema fluid white blood cell counts were 0.013–207 cells/μl (mean 42.0 cells/μl) with 41–94% neutrophils. The edema fluid red blood cell counts were 0.28–315 cells/μl (mean 64.4 cells/μl).
Resolution of alveolar edema
Serial sampling of pulmonary edema fluid allowed calculation of the net rate of alveolar fluid clearance in three patients. All of these patients had intact alveolar fluid clearance (Table 1), ranging from 4–19%/h with a mean of 9.8±8.0%/h. Over the time frame studied, the presence of intact clearance was not associated with any change in ventilator parameters, such as tidal volume or the level of positive end-expiratory pressure (PEEP). All patients were ventilated in an intermittent mandatory ventilation mode with tidal volumes averaging 10 ml/kg (range 5.9–14.9 ml/kg). PEEP levels ranged from 5 to 12 cmH20 and the level of PEEP was not changed during the time of sequential edema fluid sampling. There was no correlation between higher tidal volumes or PEEP and higher protein concentrations in the edema fluid.
Cardiac and hemodynamic data
Normal left ventricular systolic function was documented in four of the seven patients by echocardiography. Hemodynamic monitoring (two patients with a central venous catheter, one with pulmonary artery catheter) was performed on the day of the drainage procedure in three patients. Patient 4 had a pulmonary arterial wedge pressure of 16 mmHg at the time of edema fluid sampling. Patients 1 and 6 had central venous pressures of 5–9 and 8–12 mmHg, respectively, on the day of edema fluid sampling.
Radiographic data
All seven patients had patchy or diffuse infiltrates in the re-expanded lung consistent with re-expansion edema. Review of serial radiographs demonstrated that the infiltrates developed after the re-expansion of the lung in all patients. There was no radiographic evidence of pulmonary edema prior to the drainage procedures.
Discussion
The primary objective of this observational study was to test the hypothesis that re-expansion pulmonary edema is due to increased protein permeability of the alveolar-capillary barrier. This was accomplished by measuring the ratio of pulmonary edema fluid to plasma protein concentration at the onset of re-expansion edema. The second objective was to study the alveolar fluid transport capacity of the re-expanded lung by measuring the protein concentration in serial pulmonary edema fluid samples in a subset of the patients in whom serial samples were available.
Unexpectedly, the mean edema fluid to plasma protein ratio was 0.58±0.21 and the initial edema fluid to plasma protein ratio was less than or equal to 0.65 in four of the seven patients, suggestive of a contribution of hydrostatic mechanisms to the edema formation. There was no evidence that elevated intravascular pressures contributed to edema formation. Analysis of the hemodynamic parameters and echocardiography did not reveal any evidence of left ventricular systolic dysfunction or volume overload in this group of patients. This finding is consistent with prior reports in which re-expansion pulmonary edema has been noted to occur in patients with documented hypovolemia [27, 28].
The pathogenesis of re-expansion pulmonary edema is unknown. A number of mechanisms have been suggested, including increased permeability of pulmonary capillaries, a decrease in perivascular pressure, ischemia reperfusion injury, free radical injury, the effects of a high negative pressure, decreased functional surfactant, atelectasis, hypoperfusion, tissue injury secondary to stretching, airway obstruction, hypoxia and decreased lymph flow [8, 29]. During the re-expansion, heterogeneous areas of hypoxic vasoconstriction may lead to areas of under-perfusion and over-perfusion [30]. Higher perfusion in areas of high negative pressure or decreased lymph flow as well as pulmonary venous constriction may lead to hydrostatic edema.
The finding of a low edema fluid to plasma protein ratio in the majority of our patients suggests that hydrostatic forces probably play an important role in the development of re-expansion edema. Also, the edema fluid to plasma protein ratio in three of the seven patients in whom the level was greater than 0.65 was only very modestly elevated with a mean value of 0.72. In our prior studies of patients with clinical acute lung injury and the acute respiratory distress syndrome, the alveolar capillary barrier permeability was much higher, with mean initial edema fluid to plasma protein ratios typically greater than 0.90. For example, in three recent studies of a total of 108 patients with acute lung injury and the acute respiratory distress syndrome, the mean edema fluid/plasma protein ratio was 0.92 [31], 0.94 [17] and 0.98 [25], indicating that the level of 0.72 in three of the seven patients in this study reflects only a modest increase in alveolar-capillary permeability to protein.
Our findings stand in contrast to two previous reports of increased protein concentrations in the pulmonary edema fluid of some patients with re-expansion pulmonary edema [6, 32]. However, only three patients were included in these studies. Furthermore, the time interval between the collection of pulmonary edema after the onset of pulmonary edema was not reported. If there was a delay in collecting the edema fluid, then re-absorption of salt and water would result in an increased protein concentration in the edema fluid, a finding that would then be misinterpreted as indicative of increased permeability edema as the primary mechanism for edema formation. In our study, the initial samples were collected as soon as clinically feasible after the onset of re-expansion edema, and all were collected within 6 h of the inciting drainage procedure (mean 3.1±1.8 h). There was no correlation between the time of sampling and edema fluid to plasma protein ratio (Table 2).
Based on the new data in this study, hydrostatic mechanisms appear to contribute to the development of acute lung edema in re-expansion pulmonary edema. In some patients there is a small increase in protein permeability. One potential unifying explanation for the findings in this study is that hydrostatic forces initiate edema formation after acute re-expansion of the lung; but in some patients there is an associated stress capillary failure that results in a transient increase in protein permeability, as others have described [33, 34]. In fact, West and colleagues have proposed that alveolar capillary stress failure can occur in the setting of heterogeneous re-expansion of atelectatic lung, leading to a mixed picture of protein-poor (hydrostatic) and increased permeability edema [34]. This concept of high pressure-induced traumatic breaks in the basement membranes of the alveolar capillary barrier has been demonstrated in animal models, cardiogenic pulmonary edema, neurogenic pulmonary edema and high altitude pulmonary edema [34]. Thus, hydrostatic forces in patients with clinical re-expansion pulmonary edema may occur in some subjects without injury to the alveolar capillary barrier, while leading to injury in others.
This interpretation is also consistent with several previous experimental reports that have found that re-expansion pulmonary edema is characterized by the recruitment of neutrophils, the release of neutrophil granular contents in the air spaces and increased vascular permeability that are correlated with increased interleukin-8 and monocyte chemotactic protein concentrations in the bronchoalveolar lavage fluid [6, 10, 11, 35]. A number of clinical studies have reported the presence of inflammatory biologic markers in patients with hydrostatic pulmonary edema [36, 37]. In addition, patients with hydrostatic edema have elevated levels of platelet activating factor in their bronchoalveolar lavage fluid and significantly negative transpulmonary gradients of E-selectin and L-selectin in their serum [38, 39]. Finally, in experimental studies, a pure hydrostatic pressure elevation in lung capillaries increases the endothelial expression of P-selectin, suggesting that a hydrostatic stress alone may induce white cell adhesion and inflammation [40, 41]. In keeping with this hypothesis, patients with hydrostatic pulmonary edema may have significant neutrophilia in their pulmonary edema fluid [24].
Alveolar fluid clearance, an important function of the alveolar epithelium, was intact in the three patients in whom it was measured. Net alveolar fluid clearance was quantified by measuring serial protein concentrations in the pulmonary edema fluid, a method that has been validated and used by many investigators to quantify alveolar fluid clearance [16, 17, 24, 25, 42]. Although the sample size was small, the presence of intact alveolar fluid clearance is consistent with previous measurements of alveolar fluid clearance in patients with hydrostatic pulmonary edema [24].
In conclusion, the results of this study provide some evidence that hydrostatic forces in the lung microcirculation generated by rapid re-expansion of the collapsed lung may contribute to clinical re-expansion pulmonary edema.
References
Sautter RD, Dreher WH, MacIndoe JH, Myers WO, Magnin GE (1971) Fatal pulmonary edema and pneumonitis after reexpansion of chronic pneumothorax. Chest 60:399–401
Mahajan VK, Simon M, Huber GL (1979) Reexpansion pulmonary edema. Chest 75:192–194
Sprung CL (1984) Reexpansion pulmonary edema. J Emerg Med 1:452–453
Matsuura Y, Nomimura T, Murakami H, Matsushima T, Kakehashi M, Kajihara H (1991) Clinical analysis of reexpansion pulmonary edema. Chest 100:1562–1566
Kernodle DS, DiRaimondo CR, Fulkerson WJ (1984) Reexpansion pulmonary edema after pneumothorax. South Med J 77:318–322
Suzuki S, Niikawa H, Shibuya J, Hosaka T, Maeda S, Suzuki T, Handa M (2002) Analysis of edema fluids and histologic features of the lung in reexpansion pulmonary edema during video-assisted thoracoscopic surgery. J Thorac Cardiovasc Surg 123:387–389
Tarver RD, Broderick LS, Conces DJJ (1996) Reexpansion pulmonary edema. J Thorac Imaging 11:198–209
Mahfood S, Hix WR, Aaron BL, Blaes P, Watson DC (1988) Reexpansion pulmonary edema. Ann Thorac Surg 45:340–345
Jackson RM, Veal CF, Alexander CB, Brannen AL, Fulmer JD (1988) Neutrophils in reexpansion pulmonary edema. J Appl Physiol 65:228–234
Nakamura M, Fujishima S, Sawafuji M, Ishizaka A, Oguma T, Soejima K, Matsubara H, Tasaka S, Kikuchi K, Kobayashi K, Ikeda E, Sadick M, Hebert CA, Aikawa N, Kanazawa M, Yamaguchi K (2000) Importance of interleukin-8 in the development of reexpansion lung injury in rabbits. Am J Respir Crit Care Med 161:1030–1036
Sakao Y, Kajikawa O, Martin T, Nakahara Y, Hadden WR, Harmon CL, Miller EJ (2001) Association of IL-8 and MCP-1 with the development of reexpansion pulmonary edema in rabbits. Ann Thorac Surg 71:1825–1832
Sprung CL, Loewenherz JW, Baier H, Hauser MJ (1981) Evidence for increased permeability in reexpansion pulmonary edema. Am J Med 71:497–500
Suzuki S, Tanita T, Koike K, Fujimura S (1992) Evidence of acute inflammatory response in reexpansion pulmonary edema. Chest 101:275–276
Tan HC, Mak KH, Johan A, Wang YT, Poh SC (2002) Cardiac output increases prior to development of pulmonary edema after re-expansion of spontaneous pneumothorax. Respir Med 96:461–465
Hastings RH, Grady M, Sakuma T, Matthay MA (1992) Clearance of different-sized proteins from the alveolar space in humans and rabbits. J Appl Physiol 73:1310–1316
Matthay MA, Wiener-Kronish JP (1990) Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 142:1250–1257
Ware LB, Golden JA, Finkbeiner WE, Matthay MA (1999) Alveolar epithelial fluid transport capacity in reperfusion lung injury after lung transplantation. Am J Respir Crit Care Med 159:980–988
Berthiaume Y, Albertine KH, Grady M, Fick G, Matthay MA (1989) Protein clearance from the air spaces and lungs of unanesthetized sheep over 144 h. J Appl Physiol 67:1887–1897
Fein A, Grossman RF, Jones JG et al.(1979) The value of edema protein measurements in patients with pulmonary edema. Am J Med 67:32–39
Matthay MA, Folkesson HG, Clerici C (2002) Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev 82:569–600
Berthiaume Y, Staub NC, Matthay MA (1987) Beta-adrenergic agonists increase lung liquid clearance in anesthetized sheep. J Clin Invest 79:335–343
Berthiaume Y, Broaddus VC, Gropper MA, Tanita T, Matthay MA (1988) Alveolar liquid and protein clearance from normal dog lungs. J Appl Physiol 65:585–593
Wiener-Kronish JP, Broaddus VC, Albertine K, Gropper M, Matthay MA, Staub N (1988) Relationship of pleural effusions to increased permeability pulmonary edema in anesthetized sheep. J Clin Invest 82:1422–1429
Verghese GM, Ware LB, Matthay BA, Matthay MA (1999) Alveolar epithelial fluid transport and the resolution of clinically severe hydrostatic pulmonary edema. J Appl Physiol 87:1301–1312
Ware LB, Matthay MA (2001) Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 163:1376–1383
Smith WS, Matthay MA (1997) Evidence for a hydrostatic mechanism in human neurogenic pulmonary edema. Chest 111:1326–1333
Cinella G, Dambrosio M, Brienza N, Ranieri VM (1998) Reexpansion pulmonary edema with acute hypovolemia. Intensive Care Med 24:1117
Haljamae H (1985) Rationale for the use of colloids in the treatment of shock and hypovolemia. Acta Anaesthesiol Scand Suppl 82:48–54
Woodring JH (1997) Focal reexpansion pulmonary edema after drainage of large pleural effusions: clinical evidence suggesting hypoxic injury to the lung as the cause of edema. South Med J 90:1176–1182
Hultgren HN (1997) High altitude pulmonary edema: hemodynamic aspects. Int J Sports Med 18:20–25
Geiser T, Atabai K, Jarreau PH, Ware LB, Pugin J, Matthay MA (2001) Pulmonary edema fluid from patients with acute lung injury augments alveolar epithelial repair by an IL-1β dependent mechanism. Am J Respir Crit Care Med 163:1384–1388
Marland AM, Glauser FL (1982) Hemodynamic and pulmonary edema protein measurements in a case of reexpansion pulmonary edema. Chest 81:250–251
West JB (2000) Invited review: pulmonary capillary stress failure. J Appl Physiol 89:2483–2489
West JB, Mathieu-Costello O (1998) Stress-induced injury of pulmonary capillaries. Proc Assoc Am Physicians 110:506–512
Nakamura H, Ishizaka A, Sawafuji M, Urano T, Fujishima S, Sakamaki F, Sayama K, Kawamura M, Kato R, Kikuchi K et al. (1994) Elevated levels of interleukin-8 and leukotriene B4 in pulmonary edema fluid of a patient with reexpansion pulmonary edema. Am J Respir Crit Care Med 149:1037–1040
Swenson ER, Maggiorini M, Mongovin S, Gibbs JS, Greve I, Mairbaurl H, Bartsch P (2002) Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor. JAMA 287:2228–2235
Nakos G, Pneumatikos J, Tsangaris I, Tellis C, Lekka M (1997) Proteins and phospholipids in BAL from patients with hydrostatic pulmonary edema. Am J Respir Crit Care Med 155:945–951
Gaillard D, Hinnrasky J, Coscoy S, Hofman P, Matthay MA, Puchelle E, Barbry P (2000) Early expression of beta- and gamma-subunits of epithelial sodium channel during human airway development. Am J Physiol Lung Cell Mol Physiol 278:L177–L184
Geppert A, Zorn G, Heinz G, Huber K, Siostrzonek P (2001) Soluble selectins in the pulmonary and systemic circulation in acute cardiogenic and non-cardiogenic pulmonary failure. Intensive Care Med 27:521–527
Kuebler WM, Ying X, Bhattacharya J (1999) Pressure-induced endothelial Ca(2+) oscillations in lung capillaries. Am J Physiol Lung Cell Mol Physiol 282:L917–L923
Kuebler WM, Ying X, Singh B, Issekutz AC, Bhattacharya J (1999) Pressure is proinflammatory in lung venular capillaries. J Clin Invest 104:495–502
Matthay MA (1991) Resolution of pulmonary edema. New insights. West J Med 154:315–321
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by NIH HL51856 (MAM) and NIH HL70521 (LBW)
Rights and permissions
About this article
Cite this article
Sue, R.D., Matthay, M.A. & Ware, L.B. Hydrostatic mechanisms may contribute to the pathogenesis of human re-expansion pulmonary edema. Intensive Care Med 30, 1921–1926 (2004). https://doi.org/10.1007/s00134-004-2379-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-004-2379-1